Solaraze Gel 3%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Solaraze Gel 3%, covering 2014-01-22 to 2017-05-05. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp [Phase 3]